{"schema_version":"alpha-company-profile-public-v2","slug":"alnylam-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc","published_on":"2026-09-13T04:45:14.103186+00:00","last_reviewed_on":"2026-09-13T04:45:14.103186+00:00","identity":{"legal_name":"ALNYLAM PHARMACEUTICALS, INC.","display_name":"ALNYLAM PHARMACEUTICALS, INC.","headline":"Canonical company identity and public leadership record.","description":"Alpha's canonical identity and public leadership record for ALNYLAM PHARMACEUTICALS, INC..","ten_second_view":"This Company Profile publishes only Alpha's canonical identity and evidence-backed public leadership records. Unavailable fields are not inferred.","legal_form":"Not publicly asserted","incorporation":"Not publicly asserted","headquarters":"US","headquarters_address":{"locality":"Not publicly asserted","region":null,"country":"US"},"operating_presence":["US"],"website":"https://www.alnylam.com","cik":"0001178670","logo":"https://cdn.brandfetch.io/domain/alnylam.com/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","logo_source":"brandfetch","logo_domain":"alnylam.com","profile_mark":{"src":"https://cdn.brandfetch.io/domain/alnylam.com/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","alt":"ALNYLAM PHARMACEUTICALS, INC. logo","width":256,"height":256,"source":"brandfetch"}},"entity_status":{"ownership_type":"unknown","listing_status":"listed","label":"Public listing published","explanation":"The canonical public record includes at least one active security listing.","source_id":"alpha-canonical-company-record","reviewed_on":"2026-09-13T04:45:14.103186+00:00"},"security_listings":[{"ticker":"ALNY","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true,"source_id":"alpha-canonical-company-record"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market data is not published in this Company Profile."},"profile_tags":["Canonical identity","Public leadership"],"trust_summary":"Canonical identity published; broader company intelligence is not asserted.","facts":[{"label":"Legal name","value":"ALNYLAM PHARMACEUTICALS, INC.","source_id":"alpha-canonical-company-record"},{"label":"Country","value":"US","source_id":"alpha-canonical-company-record"},{"label":"Sector","value":"Healthcare","source_id":"alpha-canonical-company-record"}],"operating_model":{"eyebrow":"Operating record","title":"Published operating structure","units":[]},"governance":{"summary":"Only current, confirmed leadership roles with public evidence are included in the canonical projection.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","disclosures":[]},"alpha_opinion":{"status":"Not published","label":"No Alpha opinion published","explanation":"This identity record is not an Alpha rating, score, or investment opinion."},"report":{"status":"Not published","label":"No governed report published","explanation":"No governed company report is attached to this profile.","href":null},"actions":[{"label":"Visit official website","href":"https://www.alnylam.com","emphasis":"primary"}],"related_records":[],"evidence":[{"id":"alpha-canonical-company-record","label":"Alpha canonical company public projection","href":"/api/public/companies/alnylam-pharmaceuticals-inc","source_type":"canonical_identity","supports":["Company identity","Published leadership","Entity status boundary"],"status":"published","reviewed_on":"2026-09-13T04:45:14.103186+00:00"}],"permissions":[{"label":"Public retrieval","allowed":true},{"label":"Agent retrieval","allowed":true},{"label":"Redistribution","allowed":false},{"label":"Model training","allowed":false},{"label":"Relationship pathfinding","allowed":false},{"label":"Direct contact","allowed":false}],"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":23,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":23,"under_review_claim_count":2,"owner_supplied_claim_count":0,"evidence_record_count":4,"distinct_source_count":4,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":23,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":23,"corroborated_claims":0,"sources":4,"distinct_sources":4,"role_claims":0,"last_reviewed_at":"2026-09-13T04:45:14.103186+00:00","observed_at":"2026-09-13T04:45:14.103186+00:00","freshness_days":0}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"company","slug":"alnylam-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc"},"publication":{"published_at":"2026-09-13T04:45:14.103186+00:00","last_reviewed_at":"2026-09-13T04:45:14.103186+00:00","as_of":"2026-09-13T04:45:14.103186+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}},"canonical_profile":{"schema_version":"alpha-company-profile-public-v1","slug":"alnylam-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc","as_of":"2026-09-13T04:45:14.103186+00:00","last_reviewed_at":"2026-09-13T04:45:14.103186+00:00","identity":{"legal_name":"ALNYLAM PHARMACEUTICALS, INC.","display_name":"ALNYLAM PHARMACEUTICALS, INC.","description":null,"jurisdiction":null,"country":"US","sector":"Healthcare","industry":null,"website":"https://www.alnylam.com","website_provenance":null,"logo_url":null,"logo_media":null,"status":"active","cik":"0001178670","entity_subtype":null,"legal_entity_status":null},"security_listings":[{"mic":"XNAS","ticker":"ALNY","currency":null,"exchange":"NASDAQ","sort_key":0,"valid_to":null,"confidence":0.95,"is_primary":true,"listing_id":"d82dc695-d325-46c0-a4f2-e9510ca16d06","source_url":"https://www.sec.gov/files/company_tickers_exchange.json","valid_from":null,"observed_at":"2026-07-11T00:28:32+00:00","source_name":"sec_company_tickers_exchange","source_tier":1,"exchange_name":"NASDAQ","security_type":"equity","listing_status":"active","last_checked_at":"2026-09-02T01:48:40.989053+00:00"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market observations are unpublished. Listing identity remains available from the governed source set."},"index_memberships":[],"index_membership_history":[],"index_membership_contract":{"schema_version":"alpha-index-membership-public-v1","as_of_date":"2026-09-13","tracked_universe_complete":false,"permissions":{"public_retrieval":true,"agent_retrieval":false,"redistribution":false,"model_training":false},"limitations":["Only source-backed memberships with an explicit public redistribution basis are returned.","Absence from Alpha tracked indices does not establish absence from every market index.","Provider announcements and effective membership are represented as distinct states.","Alpha AI 100 is not published as a current public index membership."]},"leadership":{"board":[{"person_slug":"amy-w-schulman","display_name":"Amy W. Schulman","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2014-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","source_url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-06","last_checked_at":"2026-04-24T15:56:01.293+00:00"},"headshot_url":null},{"person_slug":"colleen-f-reitan","display_name":"Colleen F. Reitan","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","source_url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-06","last_checked_at":"2026-04-24T15:56:01.293+00:00"},"headshot_url":null},{"person_slug":"david-e-i-pyott","display_name":"David E.I. Pyott","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","source_url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-06","last_checked_at":"2026-04-24T15:56:01.293+00:00"},"headshot_url":null},{"person_slug":"dennis-a-ausiello","display_name":"Dennis A. Ausiello","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2012-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","source_url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-06","last_checked_at":"2026-04-24T15:56:01.293+00:00"},"headshot_url":null},{"person_slug":"elliott-sigal","display_name":"Elliott Sigal","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","source_url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-06","last_checked_at":"2026-04-24T15:56:01.293+00:00"},"headshot_url":null},{"person_slug":"margaret-a-hamburg","display_name":"Marc D. Hamburg","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","source_url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-06","last_checked_at":"2026-04-24T15:56:01.293+00:00"},"headshot_url":null},{"person_slug":"olivier-brandicourt","display_name":"Olivier Brandicourt","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","source_url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-06","last_checked_at":"2026-04-24T15:56:01.293+00:00"},"headshot_url":null},{"person_slug":"peter-n-kellogg","display_name":"Peter N. Kellogg","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","source_url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-06","last_checked_at":"2026-04-24T15:56:01.293+00:00"},"headshot_url":null},{"person_slug":"stuart-a-arbuckle","display_name":"Stuart A. Arbuckle","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2026-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","source_url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-06","last_checked_at":"2026-04-24T15:56:01.293+00:00"},"headshot_url":null},{"person_slug":"yvonne-l-greenstreet-2","display_name":"Yvonne L. Greenstreet","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2021-01-01","end_date":null,"verification_status":"confirmed","confidence":0.85,"evidence":{"document_title":"Alnylam Pharmaceuticals DEF 14A 2026-04-06","source_url":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm","source_type":"sec_proxy","published_at":null,"effective_date":"2026-04-06","last_checked_at":"2026-04-24T15:56:01.293+00:00"},"headshot_url":null}],"executives":[{"person_slug":"bryan-andrew-supran","display_name":"Bryan Andrew Supran","role_category":"executive","title":"Chief Legal Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.86,"evidence":{"document_title":"Alnylam Pharmaceuticals key executives","source_url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_type":"other","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T06:25:13.406701+00:00"},"headshot_url":null},{"person_slug":"christine-regan-akinc","display_name":"Christine Regan Akinc","role_category":"executive","title":"Chief Corporate Communications Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.86,"evidence":{"document_title":"Alnylam Pharmaceuticals key executives","source_url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_type":"other","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T06:25:11.677388+00:00"},"headshot_url":null},{"person_slug":"jeffrey-v-poulton","display_name":"Jeffrey V. Poulton","role_category":"executive","title":"Chief Financial Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"ALNY executive roster source","source_url":null,"source_type":"sec_filing","published_at":null,"effective_date":"2026-05-03","last_checked_at":"2026-05-03T15:43:13.227197+00:00"},"headshot_url":null},{"person_slug":"kevin-joseph-fitzgerald","display_name":"Kevin Joseph Fitzgerald","role_category":"executive","title":"Executive Vice President, Chief Scientific Officer and Head of Early Research & Early Development","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.86,"evidence":{"document_title":"Alnylam Pharmaceuticals key executives","source_url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_type":"other","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T06:25:12.108589+00:00"},"headshot_url":null},{"person_slug":"piyush-sharma","display_name":"Piyush Sharma","role_category":"executive","title":"Chief Ethics & Compliance Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.86,"evidence":{"document_title":"Alnylam Pharmaceuticals key executives","source_url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_type":"other","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T06:25:14.305037+00:00"},"headshot_url":null},{"person_slug":"pushkal-garg","display_name":"Pushkal Garg","role_category":"executive","title":"EVice President of Development & Medical Affairs and Chief Research & Dev. Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.86,"evidence":{"document_title":"Alnylam Pharmaceuticals key executives","source_url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_type":"other","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T06:25:12.543583+00:00"},"headshot_url":null},{"person_slug":"timothy-j-maines","display_name":"Timothy J. Maines","role_category":"executive","title":"Chief Technical Operations & Quality Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.86,"evidence":{"document_title":"Alnylam Pharmaceuticals key executives","source_url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_type":"other","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T06:25:14.750026+00:00"},"headshot_url":null},{"person_slug":"tolga-tanguler","display_name":"Tolga Tanguler","role_category":"executive","title":"Executive VP & Chief Commercial Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.86,"evidence":{"document_title":"Alnylam Pharmaceuticals key executives","source_url":"https://financialmodelingprep.com/stable/key-executives?symbol=ALNY","source_type":"other","published_at":null,"effective_date":"2026-04-24","last_checked_at":"2026-04-24T06:25:15.164711+00:00"},"headshot_url":null},{"person_slug":"yvonne-l-greenstreet-2","display_name":"Yvonne L. Greenstreet","role_category":"executive","title":"President and Chief Executive Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"ALNY executive roster source","source_url":null,"source_type":"sec_filing","published_at":null,"effective_date":"2026-05-03","last_checked_at":"2026-05-03T15:43:13.227197+00:00"},"headshot_url":null}],"coverage":{"schema_version":"alpha-leadership-coverage-v1","board_roster_scope":"def_14a_current_directors","executive_roster_scope":"disclosed_officers_only","neo_set_status":"NOT_ASSERTED","board_roster_complete":false,"neo_set_complete":false,"notes":["Empty executives is NOT_ASSERTED, not a complete named-executive-officer set.","Form 4 occupancy is not a DEF 14A board.","Unconfirmed current sec_proxy DEF 14A directors may project. Confirmed is not required.","Unconfirmed current executives with first-party issuer evidence (source_url + effective date) may project.","Company-page directors do not require people.public_profile_enabled.","Completeness compares the latest first-party roster with the public projection; a source older than 180 days is STALE.","Do not remap HONA to HON 0000773840. Do not merge XOM 0000034088 with 0002115436.","Person match is projection-only. Name-only Person merges are forbidden."],"completeness":{"reasons":["NO_LEADERSHIP_SOURCE"],"board_completeness":"NOT_REVIEWED","completeness_schema":"alpha-leadership-completeness-v1","executive_team_completeness":"NOT_REVIEWED"},"parser_bleed_excluded":true,"former_titles_excluded":true,"identity_merge_forbidden":true,"form4_occupancy_is_not_board":true}},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"structured_data":{"@context":["https://schema.org",{"alpha":"https://alpha.ac/ns/","indexMembership":"alpha:indexMembership","indexProvider":"alpha:indexProvider","indexMembershipStatus":"alpha:indexMembershipStatus","indexEffectiveDate":"alpha:indexEffectiveDate","indexAnnouncementDate":"alpha:indexAnnouncementDate","indexRemovalDate":"alpha:indexRemovalDate","lastVerifiedAt":"alpha:lastVerifiedAt","verificationStatus":"alpha:verificationStatus","evidence":"alpha:evidence"}],"@type":"ProfilePage","@id":"https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc#profile","url":"https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc","dateModified":"2026-09-13T04:45:14.103186+00:00","mainEntity":{"@type":"Organization","@id":"https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc#organization","legalName":"ALNYLAM PHARMACEUTICALS, INC.","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc","sameAs":["https://www.alnylam.com"],"addressCountry":"US","indexMembership":[{"@type":"alpha:IndexMembership","@id":"https://api.alpha.ac/v1/index-memberships/08df5ed8-72a0-403b-b61b-67677ac1d026","name":"Nasdaq-100","indexProvider":"Nasdaq","indexMembershipStatus":"current","indexEffectiveDate":"2026-09-01","lastVerifiedAt":"2026-09-02T01:47:46.199772+00:00","verificationStatus":"exchange_verified","evidence":"https://api.nasdaq.com/api/quote/list-type/nasdaq100","additionalProperty":[{"@type":"PropertyValue","name":"index_id","value":"alpha:index:nasdaq-100"},{"@type":"PropertyValue","name":"security_id","value":"alpha:security:023af2945f3e73073e8f3e888ca39ec4"},{"@type":"PropertyValue","name":"listing_id","value":"d82dc695-d325-46c0-a4f2-e9510ca16d06"},{"@type":"PropertyValue","name":"ticker","value":"ALNY"},{"@type":"PropertyValue","name":"exchange","value":"NASDAQ"},{"@type":"PropertyValue","name":"MIC","value":"XNAS"}]}],"member":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2014-01-01","member":{"@type":"Person","name":"Amy W. Schulman","url":"https://registry.alpha.ac/people/amy-w-schulman"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2018-01-01","member":{"@type":"Person","name":"Colleen F. Reitan","url":"https://registry.alpha.ac/people/colleen-f-reitan"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2015-01-01","member":{"@type":"Person","name":"David E.I. Pyott","url":"https://registry.alpha.ac/people/david-e-i-pyott"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2012-01-01","member":{"@type":"Person","name":"Dennis A. Ausiello","url":"https://registry.alpha.ac/people/dennis-a-ausiello"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2022-01-01","member":{"@type":"Person","name":"Elliott Sigal","url":"https://registry.alpha.ac/people/elliott-sigal"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2019-01-01","member":{"@type":"Person","name":"Marc D. Hamburg","url":"https://registry.alpha.ac/people/margaret-a-hamburg"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","member":{"@type":"Person","name":"Olivier Brandicourt","url":"https://registry.alpha.ac/people/olivier-brandicourt"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2023-01-01","member":{"@type":"Person","name":"Peter N. Kellogg","url":"https://registry.alpha.ac/people/peter-n-kellogg"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2026-01-01","member":{"@type":"Person","name":"Stuart A. Arbuckle","url":"https://registry.alpha.ac/people/stuart-a-arbuckle"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","member":{"@type":"Person","name":"Yvonne L. Greenstreet","url":"https://registry.alpha.ac/people/yvonne-l-greenstreet-2"}},{"@type":"OrganizationRole","roleName":"Chief Legal Officer","member":{"@type":"Person","name":"Bryan Andrew Supran","url":"https://registry.alpha.ac/people/bryan-andrew-supran"}},{"@type":"OrganizationRole","roleName":"Chief Corporate Communications Officer","member":{"@type":"Person","name":"Christine Regan Akinc","url":"https://registry.alpha.ac/people/christine-regan-akinc"}},{"@type":"OrganizationRole","roleName":"Chief Financial Officer","member":{"@type":"Person","name":"Jeffrey V. Poulton","url":"https://registry.alpha.ac/people/jeffrey-v-poulton"}},{"@type":"OrganizationRole","roleName":"Executive Vice President, Chief Scientific Officer and Head of Early Research & Early Development","member":{"@type":"Person","name":"Kevin Joseph Fitzgerald","url":"https://registry.alpha.ac/people/kevin-joseph-fitzgerald"}},{"@type":"OrganizationRole","roleName":"Chief Ethics & Compliance Officer","member":{"@type":"Person","name":"Piyush Sharma","url":"https://registry.alpha.ac/people/piyush-sharma"}},{"@type":"OrganizationRole","roleName":"EVice President of Development & Medical Affairs and Chief Research & Dev. Officer","member":{"@type":"Person","name":"Pushkal Garg","url":"https://registry.alpha.ac/people/pushkal-garg"}},{"@type":"OrganizationRole","roleName":"Chief Technical Operations & Quality Officer","member":{"@type":"Person","name":"Timothy J. Maines","url":"https://registry.alpha.ac/people/timothy-j-maines"}},{"@type":"OrganizationRole","roleName":"Executive VP & Chief Commercial Officer","member":{"@type":"Person","name":"Tolga Tanguler","url":"https://registry.alpha.ac/people/tolga-tanguler"}},{"@type":"OrganizationRole","roleName":"President and Chief Executive Officer","member":{"@type":"Person","name":"Yvonne L. Greenstreet","url":"https://registry.alpha.ac/people/yvonne-l-greenstreet-2"}}]},"mainEntityOfPage":"https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc"}},"canonical_source":"aegis_canonical"}